Field safety notices: Omixon Biocomputing Ltd.
Manufacturer registered in EUDAMED: SRN HU-MF-000003018 ; country: Hungary
5 authority publications by one authority, from 16 Oct 2019 to 13 Aug 2024.
Latest notice: 13 Aug 2024, ANSM, Réactifs Holotype HLA products
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Omixon Biocomputing Ltd. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
4 distinct corrective actions.
- Réactifs Holotype HLA products
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Logiciel Omixon HLA Twin CE
Source : ANSM, informations de sécurité · collected 16 Nov 2026
Corrective action: 2 publications by ANSM, from 19 Feb 2020 to 10 Mar 2020
- Logiciel Omixon HLA TWIN CE
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- ANSMFranceofficial source: Réactifs Holotype HLA 96/7 – Différentes configurations, ANSM, 2020-02-19Réactifs Holotype HLA 96/7 – Différentes configurations
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Configuration A & CE, Holotype HLA 96/7 – Configuration A & CE v2, Holotype HLA 96/7 Configuration B et CE v2
Source : ANSM, informations de sécurité · collected 16 Nov 2026